Passive

Vanguard Health Care Index Fund

Vanguard Health Care ETF, an exchange-traded share class of Vanguard Health Care Index Fund (the “Fund”), seeks to track the performance of a benchmark index that measures the investment return of health care stocks.

$308.41

Key Metrics

TER 0.09% per year
Distribution policy Distributing
Fund size USD 20,268 M
Inception date January 26, 2004
Holdings 416
Fund currency USD
Fund domicile US
Provider Vanguard
For full official fund details, factsheets, and holdings, visit investor.vanguard.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Health Care Index Fund VHT
Fund Size
$20.3B
Dividend
1.5%
Fees
0.09%
Total Stock Market Index Fund VTSAX
Fund Size
$1.99T
Dividend
1.0%
Fees
0.04%
Total Stock Market Index Fund VTI
Fund Size
$1.99T
Dividend
1.1%
Fees
0.03%
500 Index Fund VFIAX
Fund Size
$1.42T
Dividend
1.1%
Fees
0.04%
500 Index Fund VFINX
Fund Size
$1.42T
Dividend
1.0%
Fees
-
View 1339 similar ETFs →

Historical Return

Last updated: Jul 01, 2026
1 Year +19.0% +1.5% Div
3 Years (avg.) +7.2% +1.5% Div
5 Years (avg.) +3.7% +1.5% Div

Risk & Analysis Metrics

Last updated: Jul 01, 2026

Volatility

14.32% 1 Year
13.82% 3 Years
14.85% 5 Years
16.80% 10 Years

Max Drawdown

-10.73% 1 Year
-17.84% 3 Years
-17.94% 5 Years
-29.04% 10 Years

Sharpe Ratio

0.86 1 Year
0.24 3 Years
0.02 5 Years
0.31 10 Years

Return Triangle (Heatmap)

Last updated: Jul 01, 2026
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2011 7.7% 11.6% 19.9% 21.1% 17.8% 14.1% 15.0% 13.4% 14.2% 14.4% 14.9% 13.0% 12.0% 11.1% 11.2%
2012 15.7% 26.5% 25.9% 20.5% 15.5% 16.2% 14.2% 15.0% 15.2% 15.6% 13.5% 12.4% 11.4% 11.5%
2013 38.2% 31.4% 22.1% 15.4% 16.3% 14.0% 14.9% 15.1% 15.6% 13.2% 12.1% 11.0% 11.2%
2014 24.9% 14.8% 8.7% 11.4% 9.7% 11.5% 12.2% 13.1% 10.7% 9.8% 8.8% 9.2%
2015 5.6% 1.4% 7.3% 6.2% 9.0% 10.2% 11.5% 9.1% 8.2% 7.3% 7.9%
2016 -2.7% 8.1% 6.3% 9.8% 11.1% 12.5% 9.6% 8.6% 7.5% 8.1%
2017 20.1% 11.2% 14.4% 14.9% 15.8% 11.8% 10.3% 8.9% 9.4%
2018 2.9% 11.6% 13.2% 14.8% 10.2% 8.7% 7.4% 8.1%
2019 21.0% 18.7% 19.0% 12.1% 9.9% 8.1% 8.9%
2020 16.5% 18.1% 9.3% 7.3% 5.7% 7.0%
2021 19.7% 5.9% 4.4% 3.2% 5.1%
2022 -6.3% -2.5% -1.8% 1.8%
2023 1.5% 0.6% 4.6%
2024 -0.3% 6.3%
2025 13.3%

Distributions

*by ETF Portfolio Weight Last updated: Jul 01, 2026

Profit Margin Distribution

< 0%
5%
1y 3y N/A N/A
0 - 5%
15%
1y 3y N/A N/A
5 - 10%
12%
1y 3y N/A N/A
10 - 15%
18%
1y 3y N/A N/A
15 - 20%
10%
1y 3y N/A N/A
20 - 30%
21%
1y 3y N/A N/A
30 - 40%
19%
1y 3y N/A N/A
> 40%
1%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
6%
1y 3y N/A N/A
0 - 10
1%
1y 3y N/A N/A
10 - 15
5%
1y 3y N/A N/A
15 - 20
15%
1y 3y N/A N/A
20 - 25
7%
1y 3y N/A N/A
25 - 35
26%
1y 3y N/A N/A
35 - 50
32%
1y 3y N/A N/A
> 50
9%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.1%
1y 3y N/A N/A
Small Cap
1.7%
1y 3y N/A N/A
Mid Cap
5.6%
1y 3y N/A N/A
Large Cap
55.5%
1y 3y N/A N/A
Mega Cap
37.0%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Jul 01, 2026
37.0% Top 5 Holdings
51.9% Top 10 Holdings
86.6% Top 50 Holdings
94.2% Top 100 Holdings
Top 5 Companies
LLY Lilly(Eli) & Co
12.9%
JNJ Johnson & Johnson
9.0%
ABBV Abbvie Inc
6.3%
MRK Merck & Co Inc
4.7%
UNH Unitedhealth Group Inc
4.1%

Latest News

1 day ago • fool.com

Members of Congress Are Loading Up on Johnson & Johnson and UnitedHealth. Here's Why Retail Investors Should Pay Attention.

Rep. Lisa McClain (R-Mich.) has been a big buyer of Johnson & Johnson stock.
2 days ago • 247wallst.com

This ‘Dividend’ ETF Pays Just 1.2% | So Why Do Serious Investors Keep Buying It?

The WisdomTree U.S. Quality Dividend Growth Fund (NASDAQ: DGRW) pays a trailing yield of roughly 1.28%, which sounds thin for something with "Divid...
2 days ago • 247wallst.com

The Portfolio That Could Put You in a New Car Every Year for Life

The average new vehicle in the United States now costs roughly $49,000, with full-size pickups and many luxury models pushing far higher. That puts...

Average metrics of all companies in portfolio

Last updated: Jun 28, 2026
Market
Average
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $326B -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.28% 2.01%
Beta Indicates the relationship between the price performance of a share and the market. 0.6 -
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 38.08 28.61
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -48.19 -
Profitable Companies 93% -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 33.58 18.04
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.84 8.09
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 11.31 10.18
Market
Average
Enterprise Value to EBIT Enterprise Value divided by EBIT 23.83 20.33
Enterprise Value to Revenue Enterprise value divided by revenue 7.18 7.98
Total Debt to Enterprise Value Total debt divided by enterprise value 0.12 0.04
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.76 0.27
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 15.56% 20.81%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +8.3% -118.0%
Return on Equity Equity divided by market cap. 28.01% 2.67%
Return on Assets Indicates a company's profitability in relation to its total assets. 7.96% 4.17%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 15.79% 3.72%

Sectors

Manufacturing 71.9%
Finance and Insurance 6.9%
Professional, Scientific, and Technical Services 5.2%
Health Care and Social Assistance 4.1%
Wholesale Trade 3.8%
Healthcare 1.9%
Retail Trade 1.6%
Information 0.1%
Construction 0.0%
Financial Services 0.0%
Health Technology 0.0%
Other 4.5%

Countries

United States 97.0%
Ireland 2.2%
Other 0.4%
United Kingdom 0.3%
Netherlands 0.1%
Canada 0.0%
Singapore 0.0%
Switzerland 0.0%
Other 0.0%

Stock Screener

Select filters to narrow down the 384 investments below

384 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
P/E Ratio
Dividends Ratio of dividends in the last 12 months to current share price
Total Investment
Weight

Lilly(Eli) & Co

LLY - Manufacturing

Lilly(Eli) & Co

LLY - Manufacturing
Market Cap $1.14T
P/E Ratio 42.9
Dividends 0.5%
Total Investment $2.54B
Weight 12.54%

Loading details…

Johnson & Johnson

JNJ - Manufacturing

Johnson & Johnson

JNJ - Manufacturing
Market Cap $633.2B
P/E Ratio 30.3
Dividends 2.0%
Total Investment $1.77B
Weight 8.74%

Loading details…

Abbvie Inc

ABBV - Manufacturing

Abbvie Inc

ABBV - Manufacturing
Market Cap $461.26B
P/E Ratio 128.0
Dividends 2.6%
Total Investment $1.23B
Weight 6.08%

Loading details…

Merck & Co Inc

MRK - Manufacturing

Merck & Co Inc

MRK - Manufacturing
Market Cap $319.89B
P/E Ratio 36.4
Dividends 2.6%
Total Investment $928.95M
Weight 4.58%

Loading details…

Unitedhealth Group Inc

UNH - Finance and Insurance

Unitedhealth Group Inc

UNH - Finance and Insurance
Market Cap $386.29B
P/E Ratio 32.1
Dividends 2.1%
Total Investment $797.78M
Weight 3.94%

Loading details…

AMGEN Inc.

AMGN - Manufacturing

AMGEN Inc.

AMGN - Manufacturing
Market Cap $201.93B
P/E Ratio 25.8
Dividends 2.6%
Total Investment $627.68M
Weight 3.10%

Loading details…

Abbott Laboratories

ABT - Manufacturing

Abbott Laboratories

ABT - Manufacturing
Market Cap $166.15B
P/E Ratio 26.5
Dividends 2.6%
Total Investment $608.24M
Weight 3.00%

Loading details…

Thermo Fisher Scientific Inc.

TMO - Professional, Scientific, and Technical Services

Thermo Fisher Scientific Inc.

TMO - Professional, Scientific, and Technical Services
Market Cap $194.52B
P/E Ratio 28.7
Dividends 0.3%
Total Investment $591.05M
Weight 2.92%

Loading details…

Gilead Sciences, Inc.

GILD - Manufacturing

Gilead Sciences, Inc.

GILD - Manufacturing
Market Cap $162.98B
P/E Ratio 17.7
Dividends 2.5%
Total Investment $555.13M
Weight 2.74%

Loading details…

Intuitive Surgical Inc

ISRG - Manufacturing

Intuitive Surgical Inc

ISRG - Manufacturing
Market Cap $150.88B
P/E Ratio 50.9
Dividends 0.0%
Total Investment $542.17M
Weight 2.68%

Loading details…

Pfizer Inc.

PFE - Manufacturing

Pfizer Inc.

PFE - Manufacturing
Market Cap $138.61B
P/E Ratio 18.6
Dividends 7.1%
Total Investment $472.19M
Weight 2.33%

Loading details…

Danaher Corp.

DHR - Manufacturing

Danaher Corp.

DHR - Manufacturing
Market Cap $140.09B
P/E Ratio 38.1
Dividends 0.7%
Total Investment $407.74M
Weight 2.01%

Loading details…

Stryker Corp.

SYK - Manufacturing

Stryker Corp.

SYK - Manufacturing
Market Cap $125.18B
P/E Ratio 37.4
Dividends 1.1%
Total Investment $400.46M
Weight 1.98%

Loading details…

Vertex Pharmaceuticals, Inc.

VRTX - Manufacturing

Vertex Pharmaceuticals, Inc.

VRTX - Manufacturing
Market Cap $134.02B
P/E Ratio 31.0
Dividends 0.0%
Total Investment $382.62M
Weight 1.89%

Loading details…

Bristol-Myers Squibb Co.

BMY - Manufacturing

Bristol-Myers Squibb Co.

BMY - Manufacturing
Market Cap $118.71B
P/E Ratio 16.3
Dividends 4.3%
Total Investment $381.31M
Weight 1.88%

Loading details…

Mckesson Corporation

MCK - Wholesale Trade

Mckesson Corporation

MCK - Wholesale Trade
Market Cap $92.06B
P/E Ratio 20.3
Dividends 0.4%
Total Investment $368.89M
Weight 1.82%

Loading details…

Boston Scientific Corp.

BSX - Healthcare

Boston Scientific Corp.

BSX - Healthcare
Market Cap $175.45B
P/E Ratio 18.8
Dividends 0.0%
Total Investment $342.05M
Weight 1.69%

Loading details…

CVS Health Corp

CVS - Retail Trade

CVS Health Corp

CVS - Retail Trade
Market Cap $133.62B
P/E Ratio 45.3
Dividends 2.5%
Total Investment $304.39M
Weight 1.50%

Loading details…

HCA Healthcare Inc

HCA - Health Care and Social Assistance

HCA Healthcare Inc

HCA - Health Care and Social Assistance
Market Cap $91.07B
P/E Ratio 14.0
Dividends 0.7%
Total Investment $260.61M
Weight 1.29%

Loading details…

Regeneron Pharmaceuticals, Inc.

REGN - Manufacturing

Regeneron Pharmaceuticals, Inc.

REGN - Manufacturing
Market Cap $67.4B
P/E Ratio 15.4
Dividends 0.6%
Total Investment $244.58M
Weight 1.21%

Loading details…